$4450
$3560
The carrier testing services market is projected to reach US$2,310.79 million by 2031 from US$791.19 million in 2024 and to register a CAGR of 16.9% during 2025–2031.
Carrier Testing Services Market AnalysisThe primary factors driving market growth include the rising prevalence of genetic diseases, increasing personalized/preventive healthcare focus, and favorable government & regulatory support. Expanded carrier screening (ECS) adoption will create ample opportunities for the carrier testing services market in the coming years.
Carrier Testing Services Market OverviewCarrier screening is becoming a standard part of preconception and prenatal care. While North America remains the frontrunner due to its robust healthcare system and general acceptance of genetic testing, Europe is not far behind, thanks to its well-established public health policies. APAC is poised to become a rapidly growing market, with improvements in local healthcare delivery and an increasing interest in preventive genetics. In Latin America and the Middle East, the demand for such tests has been gradually growing due to the rise in awareness and the capacity to carry out ??????testing.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Carrier Testing Services Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Carrier Testing Services Market Drivers and OpportunitiesCustomize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Carrier Testing Services Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Drivers:
- Rising Prevalence of Genetic Diseases: The increasing prevalence of inherited disorders leads to the more widespread use of carrier testing to inform reproductive decisions and reduce the risk of future health problems.
- Increasing Personalized/Preventive Healthcare Focus: The growth of personalized medicine and preventive care is a positive sign that patients and doctors will utilize carrier testing as a means of identifying genetic risks beforehand and thus be able to plan for reproduction.
- Favorable Government & Regulatory Support: Encouraging policies, screening recommendations, and investments in genetic services are the primary factors enabling more people to access carrier testing, whether due to the healthcare system's standardization or integration of routine healthcare.
Market Opportunities:
- Untapped Emerging Markets in Developing Countries: Healthcare improvements and increased awareness of genetic diseases have led to a rise in demand for carrier testing in emerging markets. The dissemination of diagnostic methods in these regions is contributing to the expansion of the carrier testing market.
- Expanded Carrier Screening (ECS) Adoption: The broader use of comprehensive multi-gene panels offers the possibility of serving different populations, thereby enabling the identification of risk at an earlier stage and facilitating reproductive and clinical decisions made with greater insight.
- Expansion of At-Home Testing Kits: The rising consumer preference for tests that are easy, discreet, and can be conducted at home has led to the creation of at-home carrier kits, which enable more people to be reached outside the clinical setting and promote genetic awareness as part of their personal healthcare routine.
The carrier testing services market is segmented into various categories to provide a clearer understanding of its operations, growth potential, and current trends. Below is the standard segmentation approach used in industry reports:
By Type:
- Expanded Carrier Screening: Comprehensive multi-gene panels evaluate a wide variety of heritable conditions, providing inclusive risk detection for different populations and facilitating reproductive planning.
- Targeted Disease Carrier Screening: Concentrated tests scrutinize the specific, most common genetic disorders, typically targeted for certain ethnic groups or those with a family history, to provide a precise risk assessment with insight into the condition.
By Medical Condition:
- Pulmonary Conditions: Carrier testing identifies the genetic origin of pulmonary diseases, providing early information on conditions such as cystic fibrosis and informing reproductive and clinical decision-making.
- Hematological Conditions: Carrier identification through inherited blood disorders diagnostic testing, such as sickle cell anemia or thalassemia genetic testing, can guide families on how to manage reproductive risks and plan preventive care.
- Neurological Conditions: Genetic testing identifies carriers of inherited neurological diseases, enabling the early detection of risk and subsequent reproductive counseling.
- Other Medical Conditions: Other additional inherited disorders of metabolism and the endocrine system, as well as multisystem categories, broaden the carrier testing initiative to encompass a range of different health risks.
By End User:
- Hospital-Based Laboratories
- Diagnostic Laboratories
- Other End Users
By Geography:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Market Report Scope
Carrier Testing Services Market Share Analysis by GeographyNorth America is expected to hold a significant market share. The rising prevalence of genetic diseases, increasing personalized/preventive healthcare focus, and favorable government & regulatory support drive the market growth. Asia Pacific is expected to grow the fastest in the next few years. Emerging markets in South and Central America, the Middle East, and Africa offer untapped opportunities for carrier testing services to expand.
The growth rates of the carrier testing services market vary by region, influenced by the recommendations of regulatory agencies and medical guidelines for carrier testing services. Below is a summary of market share and trends by region:
1. North America
- Market Share: Holds a significant portion of the global market
- Key Drivers: The regional market expansion and extensive uptake are primarily influenced by the strong healthcare infrastructure, widespread genetic counselling, high awareness levels, and carrier testing, which is well-integrated into standard prenatal care.
- Trends: People are opting for comprehensive panels, and as a result, their increased incorporation into routine care is evident
2. Europe
- Market Share: Substantial share due to the increasing prevalence of pain conditions
- Key Drivers: The steady use of carrier testing in various groups of people is facilitated by the adoption of public health policies that support the cause, the implementation of national screening programs, and a focus on early detection of genetic risk.
- Trends: Expansion of national screening programs and the increasing demand for standardized testing
3. Asia Pacific
- Market Share: Fastest-growing region with rising market shares every year
- Key Drivers: The adoption of carrier testing services is progressing rapidly due to continuous healthcare investment, growing awareness among the middle class, and increasing accessibility of genomic technologies.
- Trends: Improvements in access to genomics and increased consumer awareness
4. South and Central America
- Market Share: Growing market with steady progress
- Key Drivers: The growth of local markets that have been left behind is facilitated by better diagnostic capacity, more awareness of the nature of inherited disorders, and the gradual integration of genetic services into healthcare systems.
- Trends: Increase in demand for diagnostic services
5. Middle East and Africa
- Market Share: Small market growing at a rapid pace
- Key Drivers: An increasing number of people are interested in carrier testing as a result of government-sponsored genetic health programs, the higher prevalence of some inherited diseases, and the expansion of clinical genetics facilities.
- Trends: Implementation of genetic programs
High Market Density and Competition
Competition is intense due to established players such as Eurofins Scientific SE, Illumina Inc., and Thermo Fisher Scientific Inc. Regional and niche providers, including OPKO Health Inc and Fulgent Genetics, Inc, add to the competitive landscape across different regions.
This high level of competition urges companies to stand out by offering:
- Advanced products
- Value-added services such as customization and sustainable solutions
- Competitive pricing models
- Compliance with regulatory guidelines
Opportunities and Strategic Moves
- Companies are investing in research and development, driving innovation in detection technologies. These investments improve the sensitivity and specificity, addressing specific genetic health issues in different regions.
- Manufacturers will likely focus on local production to cut costs and strengthen supply chains, especially in high-volume markets such as India.
- Invitae Corporation
- Natera, Inc.
- BGI Genomics Co., Ltd.
- Sema4 Holdings
- Centogene NV
- Luminex Corporation
- Good Start Genetics, Inc.
- PerkinElmer, Inc.
- Progenity, Inc.
- PacBio Expands PureTarget Product Suite to Enter High-Throughput Carrier Screening Market: PacBio launches enhanced PureTarget products for high-throughput carrier screening, consolidating multiple assays into a single scalable test.
- Suraksha Diagnostics launches genomics lab in eastern India with ?22 crore investment.: Suraksha Diagnostics inaugurated a genomics laboratory in Kolkata, marking one of the most extensive facilities of its kind in Eastern India. The lab addresses the increasing need for accessible genomic diagnostics in the state, aligning with broader developments in preventive healthcare and risk-based diagnostics.
The "Carrier Testing Services Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:
- Carrier testing services market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Carrier testing services market trends, and market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST and SWOT analysis
- Carrier testing services market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the carrier testing services market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The carrier testing services market is projected to reach a value of US$2,310.79 million by 2031.
The carrier testing services market is estimated to register a CAGR of 16.9% during the forecast period.
North America dominated the market in 2024.
The rising prevalence of genetic diseases, increasing personalized/preventive healthcare focus, and favorable government & regulatory support drive market growth.
Eurofins Scientific SE, Quest Diagnostics Inc, Myriad Genetics Inc, Illumina Inc, Thermo Fisher Scientific Inc., OPKO Health Inc, Laboratory Corp of America Holdings, Fulgent Genetics, Inc, MedGenome Inc, and Gene By Gene Ltd are among the key players operating in the carrier testing services market.
The List of Companies - Carrier Testing Services Market
- Eurofins Scientific SE
- Quest Diagnostics Inc
- Myriad Genetics Inc
- Illumina Inc
- Thermo Fisher Scientific Inc.
- OPKO Health Inc
- Laboratory Corp of America Holdings
- Fulgent Genetics, Inc
- MedGenome Inc
- Gene By Gene Ltd
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Carrier Testing Services Market
Dec 2025
Carrier Testing Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Expanded Carrier Screening and Targeted Disease Carrier Screening), Medical Condition (Pulmonary Conditions, Hematological Conditions, Neurological Conditions, and Other Medical Conditions), End User (Hospital-Based Laboratories, Diagnostic Laboratories, and Other End Users), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
Dec 2025
Medical Contract Manufacturing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type (Full-device Manufacturing, Sub-assembly and Components, and Materials-specific Services), Device Type (IVD Devices, Diagnostic Imaging Devices, Cardiovascular Devices, Drug Delivery Devices, Orthopedic Devices, Respiratory Care Devices, Ophthalmology Devices, Surgical Devices, Diabetes Care Devices, Dental Devices, Endoscopy and Laparoscopy Devices, Gynecology and Urology Devices, Neurology Devices, Patient Assistive Devices, and Others), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
Dec 2025
Human Albumin Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application [Therapeutic Applications (Liver and Kidney Diseases, Surgery, Hypovolemia and Hypoalbuminemia, and Others), Drug Delivery, Disease Diagnostics, Research, and Others], and End User (Hospitals and Clinics, Pharmaceutical and Biotechnological Companies, Research Institutes, Diagnostic Laboratories, Homecare Settings, and Others)
Dec 2025
Peritoneal Dialysis Equipment Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Peritoneal Dialysis Solution, Peritoneal Dialysis Catheters, Peritoneal Dialysis Transfer Sets, and Others), Dialysis Type (Continuous Ambulatory Peritoneal Dialysis (CAPD), and Automated Peritoneal Dialysis (APD)), End User (In-Center Dialysis Settings, and Home Care Settings), and Geography
Dec 2025
Hemodialysis Equipment Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Dialyzers, Dialysate, Access Products, and Others), End User (In-Center Dialysis Settings and Home Care Settings), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
Dec 2025
Urokinase API and Finished Dosage Forms Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Active Pharmaceutical Ingredient and Finished Dosage Forms), Manufacturing Process (Urine-derived, Cell Culture-based, and Recombinant Technology), Indication (Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), Catheter Occlusion, Myocardial Infarction (Heart Attack), Peripheral Arterial Occlusive Diseases, and Others), Distribution Channel (Hospital Pharmacies, Retail and Drug Stores, Direct Sales (API and FDF), and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
Dec 2025
Aesthetic Fillers and Exosomes Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type [Dermal Fillers (Calcium Hydroxylapatite, Hyaluronic Acid, Collagen, Poly-L-Lactic Acid, Polymethylmethacrylate (PMMA), Fat Fillers, and Others) and Exosome-Based Aesthetic Products (Human-derived, Animal-derived, and Plant-derived)], Route of Administration [Injectable, Topical (Serum, Cream, Mask, and Others)], Application (Skin Rejuvenation, Wrinkle Reduction and Fine Line Correction, Facial Contouring, Lip Augmentation, Scar and Pigmentation, Post-procedure Recovery, Hair Restoration, and Others), End User (Hospitals, Dermatology Clinics, Medical Spas, and Others), and Geography (North America, Europe, and Middle East)
Dec 2025
Veterinary Diagnostics Products Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Kits and Reagents [ELISA Test Kits, Antibodies Test Kits, Polymerase Chain Reaction (PCR) Test Kits, Hematology Test Kits, Biochemistry Test Kits, Immunoassay Reagents, and Others]and Analyzers [Biochemistry Analyzers, Hematology Analyzers, Immunoassay Analyzers, PCR Analyzers, and Others]), Animal Type (Companion Animal [Dogs, Cats, Horses, and Others] and Livestock Animal [Cattles, Pigs, Poultry, and Others]), Application (Infectious Diseases [Rabies, Avian Influenza, Leishmania, Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection, and Others] and Non-Infectious Diseases [Pneumonia, Gastritis, Bronchitis, and Others]), End User (Public Healthcare Facilities and Private Healthcare Facilities), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)